Shih‐Feng Cho

Also affiliated with Kaohsiung Medical University Chung-Ho Memorial Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Bispecific antibodies in multiple myeloma treatment: A journey in progress”.

Bispecific antibodies in multiple myeloma treatment: A journey in progress

Frontiers in Oncology(2022)10.3389/fonc.2022.1032775

N/A

0.609DataRank · unranked

57 citations

Tsung‐Jang Yeh, Kenneth C. Anderson, Yu-Tzu Tai, Shih‐Feng Cho

BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma

Cancers(2020)10.3390/cancers12061473

N/A

0.601DataRank · unranked

54 citations

Liang Lin, Lijie Xing, Yuyin Li, Tengteng Yu, Kenneth C. Anderson +2 more

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

Blood Cancer Journal(2020)10.1038/s41408-020-00378-z

N/A

0DataRank · unranked

44 citations

Bharat K. R. Chaganty, Liang Lin, Lijie Xing, Boopathy Ramakrishnan, Kenneth Wen +18 more

Promising Antigens for the New Frontier of Targeted Immunotherapy in Multiple Myeloma

Cancers(2021)10.3390/cancers13236136

N/A

0DataRank · unranked

39 citations

Lijie Xing, Kenneth C. Anderson, Yu‐Tzu Tai, Shih‐Feng Cho

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

Blood Cancer Journal(2022)10.1038/s41408-022-00716-3

N/A

0DataRank · unranked

54 citations

Tengteng Yu, Liang Lin, Lijie Xing, Shih‐Feng Cho, Kenneth Wen +9 more

Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression

(2023)10.1158/1078-0432.c.6530600.v1

N/A

0DataRank · unranked

0 citations

Su Wang, Jiye Liu, Tengteng Yu, Hailin Chen, Kenneth Wen +11 more